To test whether the human 12-LOX inhibitor VLX-1005 (14) (Figure 1B) phenocopies deletion of the enzyme in our human gene replacement mice, we employed a similar STZ diabetes induction protocol. This evidence concerns the gene ALOX15 and diabetes mellitus.